Loading...
Dernières publications
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
-
Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
Chiffres clés
54
Publications avec texte intégral
Open Access
46 %
Mots clés
Interferon
Lamin A/C nuclei
Thymus
Th17 cells
Centres germinatifs ectopiques
CCL21
MiR-125
COVID-19
Etiology
Heart failure
Neuromuscular junction
Macrophages
Gd T cells
Innate immunity
Inflammation
Autoimmune disease
Max
Autoimmune diseases
Adaptive immunity
Myasthenia gravis
Autoimmunity
Acides nucléiques endogènes
Clinical cell transplantation
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
Chemokines
Immunity
Interferon type I
Germinal centers
Acetylcholine receptor
Interleukine-23
Myoblasts
Gender
Human myoblasts
Interféron de type I
BAFF
PBMC
Interferon de type I
MG patients
Experimental autoimmune myasthenia gravis
Exercise
Interferon type-I
LMNA
Myasthenia Gravis MG
Acetylcholine receptors
Chemokine
Ectopic germinal centers
B cells
Animal models
COX2
Conduction disease
Genetic associations
AChR antibodies
Antimir-150
CXCL13-CXCR5
Ferrites
Immunotherapy
Auto-immunité
Chronicity
Anticorps monoclonal
Myasthénie grave
Inflammatory cytokines
MYB
Chronic inflammation
Endogenous nucleic acids
Complete Freund's adjuvant
Experimental autoimmune myasthenia gravis EAMG
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
DICER
CTCF
CD31
Interferonopathy
Immune response
Interferon-β
Acetylcholine receptor antibodies
Interleukin 23
Thymic epithelial cells
Immune regulation
Cardiomyopathy
Il-23
FMR1
MiR-7
Cellules th17
M3243AG
Fragile X syndromes
Quality of life
Maladie auto-immune
Immunology and Microbiology Section
Early-onset myasthenia gravis
Thymoma
Germinal center
Disease susceptibility
Genetics
Experimental mouse models
Mass cytometry CyTOF
Long-term follow-up
Transcriptome
Experimental models
Cytokines
Interferon IFN
Glucocorticoids